Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H26N2O.ClH |
Molecular Weight | 310.862 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1
InChI
InChIKey=QEBJXWFHKCUFLS-UHFFFAOYSA-N
InChI=1S/C17H26N2O.ClH/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17;/h6-7,10-13,18H,8-9H2,1-5H3;1H
Molecular Formula | C17H26N2O |
Molecular Weight | 274.4011 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20126400 |
|||
Target ID: CHEMBL214 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20126400 |
|||
Target ID: CHEMBL2095205 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17223101 |
PubMed
Title | Date | PubMed |
---|---|---|
Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule. | 2003 Apr 4 |
|
[Latest cases of acute poisoning in clinical practice--5MeO-DIPT and GHB precursor]. | 2004 Jul |
|
Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS. | 2004 Nov |
|
A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. | 2004 Sep |
|
Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule. | 2004 Sep 29 |
|
Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry. | 2005 Aug 25 |
|
A foxy intoxication. | 2005 Feb 10 |
|
Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. | 2006 Dec 20 |
|
Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites. | 2006 Feb |
|
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. | 2006 Jan |
|
A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy. | 2006 Nov 10 |
|
Acute confusional state after designer tryptamine abuse. | 2007 Apr |
|
5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. | 2007 Apr 5 |
|
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy). | 2008 Jan |
|
A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. | 2008 Jan 15 |
|
Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. | 2008 May 30 |
|
Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats. | 2009 Jun |
|
Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management. | 2010 Jun 24 |
|
The hallucinogenic world of tryptamines: an updated review. | 2015 Aug |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:54:12 GMT 2023
by
admin
on
Sat Dec 16 08:54:12 GMT 2023
|
Record UNII |
SJ048VQB9S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m7332
Created by
admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID7048900
Created by
admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
|
PRIMARY | |||
|
SJ048VQB9S
Created by
admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
|
PRIMARY | |||
|
24802109
Created by
admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
|
PRIMARY | |||
|
2426-63-3
Created by
admin on Sat Dec 16 08:54:12 GMT 2023 , Edited by admin on Sat Dec 16 08:54:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|